Risedronate Sodium
NDC 65862-870, Risedronate Sodium, tablet, film coated, from Aurobindo Pharma Limited.
- Product NDC
- 65862-870
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206768
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65862-870 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RISEDRONATE SODIUM150 mg/1
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65862-870-03 | 65862087003 | 1 BLISTER PACK in 1 CARTON (65862-870-03) / 3 TABLET, FILM COATED in 1 BLISTER PACK |
| 65862-870-11 | 65862087011 | 1 BLISTER PACK in 1 CARTON (65862-870-11) / 1 TABLET, FILM COATED in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a42a35e6-3e08-4b4f-ae56-47d4aec2322aNADAC price for package 65862087003
GET /v1/drugs/nadac/65862087003NADAC price for package 65862087011
GET /v1/drugs/nadac/65862087011
Use it
Look up 65862-870 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65862-870 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65862-870. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.